The global neurosurgical products market is expected to grow at a CAGR of 11.2 percent from 2015 to 2022, based on a Persistence Market Research report, according to newsmaker.
Here are five notes:
1. An increasing geriatric population, growing number of brain tumor cases and increasing government funding will drive the market's growth.
2. Strict regulatory requirements, lengthy approval times for new products and alternative treatments may pose as obstacles to the market's growth.
3. Rising healthcare expenditure, an increasing geriatric population and growing number of brain tumor cases will drive the market in North America.
4. Europe and Asia-Pacific will also experience market growth.
5. Key market players include Integra LifeSciences, KARL STORTZ, Medtronic, Johnson & Johnson Services, Stryker, B. Braun Melsungen, Terumo and Elekta.